Routine CAC-scoring prior to initiation of statin therapy - a European perspective

Eur J Prev Cardiol. 2019 Sep;26(14):1559-1561. doi: 10.1177/2047487319839188. Epub 2019 Mar 26.

Authors

Amir A Mahabadi¹, Khurram Nasir², Tienush Rassaf¹

Affiliations

¹ 1 Department of Cardiology and Vascular Medicine, West German Heart and Vascular Centre Essen, University Hospital Essen, Germany.
² 2 Section of Cardiovascular Medicine, Department of Medicine, Yale School of Medicine and the Center for Outcomes Research and Evaluation (CORE), Yale New Haven Health, USA.

PMID: 30913900
DOI: 10.1177/2047487319839188

No abstract available

MeSH terms

Biomarkers / blood
Clinical Decision-Making
Coronary Artery Disease / diagnostic imaging*
Coronary Artery Disease / epidemiology
Decision Support Techniques
Dyslipidemias / blood
Dyslipidemias / diagnosis
Dyslipidemias / drug therapy*
Dyslipidemias / epidemiology
Europe
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
Lipids / blood*
Prognosis
Risk Assessment
Risk Factors
Vascular Calcification / diagnostic imaging*
Vascular Calcification / epidemiology

Substances

Biomarkers
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Lipids